Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma.
J M
JM
van Laar
M A
MA
van Buchem
N
N
Weyl
F J
FJ
Cleton
D001921:Brain / Q000187:drug effects*; D002292:Carcinoma, Renal Cell / Q000556:secondary*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000556:secondary*
D007376:Interleukin-2